NEW YORK, NY / ACCESS Newswire / December 24, 2025 / SMX’s valuation story has quietly crossed a critical threshold. The company is no longer asking the market to underwrite a concept. It is asking ...
Caliway has completed submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for a Phase 2 clinical study of CBL-514 for weight management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback